Galderma and Taro Pharmaceutical Industries have entered a definitive agreement for Taro to acquire Alchemee, formerly The Proactiv Company, from Galderma.
WHO: The Proactiv Company, makers of the #1 selling acne regimen, announced its rebranding and repositioning under the new name Alchemee after more than 25 years last December.
Galderma is the world's largest independent dermatology company, present in approximately 100 countries. Since its inception in 1981, the business has been driven by a complete dedication to dermatology, delivering an innovative, science-based portfolio of sophisticated brands and services across Aesthetics, Consumer Care, and Prescription Medicine.
Taro Pharmaceutical Industries is a multinational, science-based pharmaceutical company dedicated to meeting the needs of its customers through the discovery, development, manufacturing, and marketing of the highest-quality healthcare products.
WHY: Taro's acquisition of Alchemee adds Proactiv, a leading consumer acne brand to Taro's broad portfolio of prescription and OTC dermatology products.
IN THEIR OWN WORDS: "We are excited to add Proactiv to Taro's broad portfolio of prescription and over-the-counter dermatology products. We look forward to welcoming the Alchemee team into Taro and working together to continue to make a difference to the millions of people living with acne around the world," said Uday Baldota, Chief Executive Officer at Taro.
"We are proud of the work we have done together to serve customers suffering from acne around the world through Proactiv. I am confident that Taro is the right owner to build on Alchemee's strong foundation. Their vision is aligned to Alchemee, which comes with an incredible legacy and brand equity, and a great team with a clear plan for future success," said Flemming Ørnskov, Chief Executive Officer at Galderma.
DETAILS:
